Le Bouguénec C, Lalioui L, du Merle L, Jouve M, Courcoux P, Bouzari S, Selvarangan R, Nowicki B J, Germani Y, Andremont A, Gounon P, Garcia M I
Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, 28 rue du Docteur Roux, 75724 Paris Cedex 15, France.
J Clin Microbiol. 2001 May;39(5):1738-45. doi: 10.1128/JCM.39.5.1738-1745.2001.
Operons of the afa family are expressed by pathogenic Escherichia coli strains associated with intestinal and extraintestinal infections in humans and animals. The recently demonstrated heterogeneity of these operons (L. Lalioui, M. Jouve, P. Gounon, and C. Le Bouguénec, Infect. Immun. 67:5048-5059, 1999) was used to develop a new PCR assay for detecting all the operons of the afa family with a single genetic tool. This PCR approach was validated by investigating three collections of human E. coli isolates originating from the stools of infants with diarrhea (88 strains), the urine of patients with pyelonephritis (97 strains), and the blood of cancer patients (115 strains). The results obtained with this single test and those previously obtained with several PCR assays were closely correlated. The AfaE adhesins encoded by the afa operons are variable, particularly with respect to the primary sequence encoded by the afaE gene. The receptor binding specificities have not been determined for all of these adhesins; some recognize the Dr blood group antigen (Afa/Dr(+) adhesins) on the human decay-accelerating factor (DAF) as a receptor, and others (Afa/Dr(-) adhesins) do not. Thus, the afa operons detected in this study were characterized by subtyping the afaE gene using specific PCRs. In addition, the DAF-binding capacities of as-yet-uncharacterized AfaE adhesins were tested by various cellular approaches. The afaE8 subtype (Afa/Dr(-) adhesin) was found to predominate in afa-positive isolates from sepsis patients (75%); it was frequent in afa-positive pyelonephritis E. coli (55.5%) and absent from diarrhea-associated strains. In contrast, Afa/Dr(+) strains (regardless of the afaE subtype) were associated with both diarrhea (100%) and extraintestinal infections (44 and 25% in afa-positive pyelonephritis and sepsis strains, respectively). These data suggest that there is an association between the subtype of AfaE adhesin and the physiological site of the infection caused by afa-positive strains.
afa家族的操纵子由与人类和动物肠道及肠道外感染相关的致病性大肠杆菌菌株表达。最近发现这些操纵子具有异质性(L. Lalioui、M. Jouve、P. Gounon和C. Le Bouguénec,《感染与免疫》,67:5048 - 5059,1999年),利用这一特性开发了一种新的PCR检测方法,用单一的基因工具检测afa家族的所有操纵子。通过研究来自腹泻婴儿粪便(88株)、肾盂肾炎患者尿液(97株)和癌症患者血液(115株)的三批人类大肠杆菌分离株,验证了这种PCR方法。该单一检测方法获得的结果与先前通过几种PCR检测方法获得的结果密切相关。afa操纵子编码的AfaE黏附素是可变的,特别是在afaE基因编码的一级序列方面。并非所有这些黏附素的受体结合特异性都已确定;一些识别人类衰变加速因子(DAF)上的Dr血型抗原(Afa/Dr(+)黏附素)作为受体,而其他的(Afa/Dr(-)黏附素)则不识别。因此,本研究中检测到的afa操纵子通过使用特异性PCR对afaE基因进行亚型分析来进行表征。此外,通过各种细胞方法测试了尚未鉴定的AfaE黏附素的DAF结合能力。发现afaE8亚型(Afa/Dr(-)黏附素)在败血症患者的afa阳性分离株中占主导地位(75%);在afa阳性的肾盂肾炎大肠杆菌中很常见(55.5%),而在腹泻相关菌株中不存在。相比之下,Afa/Dr(+)菌株(无论afaE亚型如何)与腹泻(100%)和肠道外感染均有关联(在afa阳性的肾盂肾炎和败血症菌株中分别为44%和25%)。这些数据表明,AfaE黏附素的亚型与afa阳性菌株引起的感染的生理部位之间存在关联。